Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website footer’s revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:49:00.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-13T04:20:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The latest record history shows Revision: v3.7.0 as the current version, replacing the previous Revision: v3.6.6. This reflects a site update to the record history page.
    Difference
    0.1%
    Check dated 2026-09-21T22:41:07.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The record history shows a new platform revision entry: v3.6.6 superseding v3.6.5. This indicates a small software update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-08-31T16:59:54.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.5, was added to the study history. The previous revision, v3.6.4, was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-10T10:26:47.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the Study Record Versions, updating the historical record to the latest version. The previous entry v3.6.3 was removed as part of this update.
    Difference
    0.1%
    Check dated 2026-07-27T06:30:42.000Z thumbnail image

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.